Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
United States Centers for Disease Control and Prevention support for influenza surveillance, 2013-2021.
McCarron M, Kondor R, Zureick K, Griffin C, Fuster C, Hammond A, Lievre M, Vandemaele K, Bresee J, Xu X, Dugan VG, Weatherspoon V, Williams T, Vance A, Fry AM, Samaan M, Fitzner J, Zhang W, Moen A, Wentworth DE, Azziz-Baumgartner E. McCarron M, et al. Among authors: samaan m. Bull World Health Organ. 2022 Jun 1;100(6):366-374. doi: 10.2471/BLT.21.287253. Epub 2022 Apr 3. Bull World Health Organ. 2022. PMID: 35694628 Free PMC article.
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
Takashita E, Daniels RS, Fujisaki S, Gregory V, Gubareva LV, Huang W, Hurt AC, Lackenby A, Nguyen HT, Pereyaslov D, Roe M, Samaan M, Subbarao K, Tse H, Wang D, Yen HL, Zhang W, Meijer A. Takashita E, et al. Among authors: samaan m. Antiviral Res. 2020 Mar;175:104718. doi: 10.1016/j.antiviral.2020.104718. Epub 2020 Jan 28. Antiviral Res. 2020. PMID: 32004620 Free article.
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen HL, Zhang W, Meijer A, Gubareva LV. Govorkova EA, et al. Among authors: samaan m. Antiviral Res. 2022 Apr;200:105281. doi: 10.1016/j.antiviral.2022.105281. Epub 2022 Mar 12. Antiviral Res. 2022. PMID: 35292289 Free PMC article. Review.
Pandemic risk characterisation of zoonotic influenza A viruses using the Tool for Influenza Pandemic Risk Assessment (TIPRA).
Yamaji R, Zhang W, Kamata A, Adlhoch C, Swayne DE, Pereyaslov D, Wang D, Neumann G, Pavade G, Barr IG, Peiris M, Webby RJ, Fouchier RAM, Von Dobschütz S, Fabrizio T, Shu Y, Samaan M. Yamaji R, et al. Among authors: samaan m. Lancet Microbe. 2024 Oct 10:100973. doi: 10.1016/j.lanmic.2024.100973. Online ahead of print. Lancet Microbe. 2024. PMID: 39396528 Free article. Review.
A second external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region highlights improved performance by participating laboratories.
Leung VKY, Deng YM, Todd A, Peck H, Buettner I, Zakis T, Subbarao K, Barr IG, Nahapetyan K, Inbanathan FY, Samaan M, Reading PC. Leung VKY, et al. Among authors: samaan m. J Clin Virol. 2021 Sep;142:104907. doi: 10.1016/j.jcv.2021.104907. Epub 2021 Jul 7. J Clin Virol. 2021. PMID: 34274614
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
Stand-alone transarterial flow diversion for treatment of carotid cavernous fistulas.
Abramyan A, Gupta G, Sreenivasan S, Lowenthal J, Samaan M, Khandelwal P, Sundararajan S, Sun H, Nourollah-Zadeh E, Roychowdhury S. Abramyan A, et al. Among authors: samaan m. J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108047. doi: 10.1016/j.jstrokecerebrovasdis.2024.108047. Epub 2024 Oct 16. J Stroke Cerebrovasc Dis. 2024. PMID: 39424211 Free article.
249 results